Literature DB >> 12838378

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

Steven G E Marsh1, Peter Parham, Bo Dupont, Daniel E Geraghty, John Trowsdale, Derek Middleton, Carlos Vilches, Mary Carrington, Campbell Witt, Lisbeth A Guethlein, Heather Shilling, Christian A Garcia, Katharine C Hsu, Hester Wain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12838378     DOI： 10.1007/s00251-003-0571-z

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  34 in total

1.  Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires.

Authors:  K A Crum; S E Logue; M D Curran; D Middleton
Journal:  Tissue Antigens       Date:  2000-10

2.  Nomenclature for factors of the HLA system, 2002.

Authors:  S G E Marsh; E D Albert; W F Bodmer; R E Bontrop; B Dupont; H A Erlich; D E Geraghty; J A Hansen; B Mach; W R Mayr; P Parham; E W Petersdorf; T Sasazuki; G M Th Schreuder; J L Strominger; A Svejgaard; P I Terasaki
Journal:  Tissue Antigens       Date:  2002-11

3.  KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains.

Authors:  C Vilches; R Rajalingam; M Uhrberg; C M Gardiner; N T Young; P Parham
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

4.  Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules.

Authors:  R Biassoni; A Pessino; A Malaspina; C Cantoni; C Bottino; S Sivori; L Moretta; A Moretta
Journal:  Eur J Immunol       Date:  1997-12       Impact factor: 5.532

5.  Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.

Authors:  R Rajalingam; C M Gardiner; F Canavez; C Vilches; P Parham
Journal:  Tissue Antigens       Date:  2001-01

6.  Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.

Authors:  C M Gardiner; L A Guethlein; H G Shilling; M Pando; W H Carr; R Rajalingam; C Vilches; P Parham
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

7.  Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103.

Authors:  A Selvakumar; U Steffens; N Palanisamy; R S Chaganti; B Dupont
Journal:  Tissue Antigens       Date:  1997-06

Review 8.  Polymorphism and domain variability of human killer cell inhibitory receptors.

Authors:  A Selvakumar; U Steffens; B Dupont
Journal:  Immunol Rev       Date:  1997-02       Impact factor: 12.988

Review 9.  Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).

Authors:  E O Long; D F Barber; D N Burshtyn; M Faure; M Peterson; S Rajagopalan; V Renard; M Sandusky; C C Stebbins; N Wagtmann; C Watzl
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

10.  Human diversity in killer cell inhibitory receptor genes.

Authors:  M Uhrberg; N M Valiante; B P Shum; H G Shilling; K Lienert-Weidenbach; B Corliss; D Tyan; L L Lanier; P Parham
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745
View more
  50 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

2.  Amazonian Amerindians exhibit high variability of KIR profiles.

Authors:  Paloma Daguer Ewerton; Mauro de Meira Leite; Milena Magalhães; Leonardo Sena; Eduardo José Melo dos Santos
Journal:  Immunogenetics       Date:  2007-06-06       Impact factor: 2.846

3.  Pas de deux: natural killer receptors and MHC class I ligands in primates.

Authors:  Walter Lutz
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

Review 4.  Can we make a better match or mismatch with KIR genotyping?

Authors:  Rohtesh S Mehta; Katayoun Rezvani
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

5.  Functional classification of immune regulatory proteins.

Authors:  Rotem Rubinstein; Udupi A Ramagopal; Stanley G Nathenson; Steven C Almo; Andras Fiser
Journal:  Structure       Date:  2013-04-11       Impact factor: 5.006

6.  A method for killer-cell immunoglobulin-like receptor (KIR) 3DL1/3DS1 genotyping using DNA recovered from frozen plasma.

Authors:  Aniqa Shahid; Denis R Chopera; Eric Martin; Kali A Penney; M-J Milloy; Zabrina L Brumme
Journal:  J Immunol Methods       Date:  2013-03-21       Impact factor: 2.303

7.  The mosaic of KIR haplotypes in rhesus macaques.

Authors:  Jeroen H Blokhuis; Marit K van der Wiel; Gaby G M Doxiadis; Ronald E Bontrop
Journal:  Immunogenetics       Date:  2010-03-05       Impact factor: 2.846

8.  Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells.

Authors:  Laurent Abi-Rached; Achim K Moesta; Raja Rajalingam; Lisbeth A Guethlein; Peter Parham
Journal:  PLoS Genet       Date:  2010-11-04       Impact factor: 5.917

9.  KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C.

Authors:  Thorsten Graef; Achim K Moesta; Paul J Norman; Laurent Abi-Rached; Luca Vago; Anastazia M Older Aguilar; Michael Gleimer; John A Hammond; Lisbeth A Guethlein; David A Bushnell; Philip J Robinson; Peter Parham
Journal:  J Exp Med       Date:  2009-10-26       Impact factor: 14.307

10.  IPD--the Immuno Polymorphism Database.

Authors:  James Robinson; Kavita Mistry; Hamish McWilliam; Rodrigo Lopez; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2009-10-29       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.